Global Next-Generation Sequencing Market

Global Next-Generation Sequencing Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at XX % through 2020 to 2026, reaching nearly US$ 24200 Mn.

The global Next-Generation Sequencing Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Next-Generation Sequencing report also provides trends by market segments, technology, and investment with a competitive landscape.

Global Next-Generation Sequencing Market

 

Global Next-Generation Sequencing Market

To know about the Research Methodology:- Request Free Sample Report
Global Next-Generation Sequencing Market Overview:

Next-generation sequencing is also known as high-throughput sequencing because it encompasses a variety of advanced sequencing technologies. These new technologies have changed the study of genomics and molecular biology by enabling DNA and RNA to be produced more cheaply, quickly, and without creating as much cost as conventional technologies.

The sequential counting of nucleotides to immobilized and spatially arrayed RNA or DNA templates is screened using this next-generation sequencing (NGS) technology. However, there are significant differences between how these RNA or DNA templates are created and how they are interrogated to reveal their sequences.

As a result, next-generation sequencing has filled in the holes to meet these higher-level understanding requirements and has become a popular analysis method. The scalability of next-generation sequencing allows for changing the level of precision to satisfy laboratory needs, making it a digital alternative to sequence-based gene expression.
Global Next-Generation Sequencing Market

Dynamics:

Drivers:

One of the main factors driving the market’s growth is the rising prevalence of chronic medical conditions such as cancer, as well as numerous technical advances in the field of medical sciences. There has been substantial growth in the use of NGS technology as a result of the widespread use of liquid biopsies in cancer diagnostics.

Continuous technical advancements in sequencers have allowed the development of reliable, compact, and simple-to-use NGS platforms that can provide fast and accurate results while also reducing turnaround times. The launch of such products and the technology that underpins them gives players an instant competitive advantage; as a result, major corporations are continually relying on product research and development to improve their market positions and share.

Furthermore, the growing use of genome mapping programs to predict the onset of various diseases is fueling the market growth. Scientists use genetic maps to help them figure out which genes are linked to rising rates of diabetes, heart disease, obesity, cancer, and mental disorders.

Moreover, numerous technology advances and convergence of cloud-computing platforms for better data processing are positively impacting the market growth. Other trends, such as falling NGS system costs and robust research and development (R&D) activities in the fields of sequencing chemistry, molecular biology, and technological engineering, are expected to fuel the global next-generation sequencing market even more. Other trends, such as falling NGS system costs and robust research and development (R&D) activities in the fields of sequencing chemistry, molecular biology, and technological engineering, are expected to fuel the global next-generation sequencing market even more.
Restraints:

Academic R&D in developed countries is largely reliant on outside finance. Despite government and private sector initiatives to provide funding for research around the world, numerous scientific and university institutes are experiencing budget pressures when it comes to the procurement and usage of sophisticated and high-priced equipment and technology. As a consequence, advanced research facility construction and extension in university and research institutes in developed countries are slowed. This is a major impediment to the implementation of innovations like NGS in developed countries in Africa and Asia.
Global Next-Generation Sequencing Market Segment Analysis:

Based on Product & Services, the consumables dominated the industry during the forecast period. The rising number of sequencing procedures and the introduction of simple-to-use consumables are responsible for this segment’s large share.

Based on Technology, the sequencing by synthesis technology segment led the industry, in 2020. The increasing availability of NGS platforms based on sequencing by synthesis technology can be due to the significant share of the sequencing by the synthesis technology market. Furthermore, since sequencing is a capital-intensive process, it generates more sales. With an improvement in the use of WGS, the amount of data generated from sequencing projects is expected to increase. The analysis becomes difficult due to the large amounts of data produced after sequencing.

Based on Application, the diagnostics application segment dominated the industry in 2020, owing to key market players’ increased emphasis on improving NGS-based cancer and noninvasive pregnancy testing products and services (NIPT). Leading companies like Illumina are working hard to create NGS-based In Vitro Diagnostic (IVD) solutions for cancer diagnostics.

Global Next-Generation Sequencing Market

Based on End User, the academic institutes and research centers made significant improvements. The growing amount of partnerships between NGS market players and academic & research institutes can be due to this segment’s large share. This expansion can be due to the use of NGS solutions in research programs conducted by universities and research centers. Furthermore, scholarships for NGS Ph.D. projects are expected to boost demand for NGS goods and services, resulting in profitable growth in the coming years.
Global Next-Generation Sequencing Market Regional Insights:

North America has the highest share of the market, followed by Europe. This is attributed to a variety of reasons, including the availability of funds for diagnostics and genomics studies. In addition, the creation of solutions for analyzing NGS data would help the market grow in this area. Furthermore, the growing number of NGS research projects carried out in Canadian universities is driving the NGS market in this country.

Over the study period, the Asia Pacific next-generation sequencing industry is expected to expand at a profitable pace. The heavy acceptance of Next Generation Sequencing (NGS) platforms in government-sponsored research institutions engaged in population-based studies, as well as their expanded use in other industrial applications, is driving this expected market development. Big businesses are using partnerships and acquisitions to enter into low- and middle-income nations. For example, BGI, a US-based firm, bought Complete Genomics, an Asian firm, to provide DNA sequencing services for genetic research.

The industry in the Asia Pacific is expected to be driven by local companies such as BGI Genomics and NGS service providers such as First BASE Laboratories Sdn Bhd, Macrogen Asia Pacific Pte Ltd., and others. In South Asia and India, MedGenome Labs Ltd. provides NGS services to over 5,500 physicians and 1,600 hospitals.

Global Next-Generation Sequencing Market

The objective of the report is to present a comprehensive analysis of the global Next-Generation Sequencing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Next-Generation Sequencing Market dynamics, structure by analyzing the market segments and project the global Next-Generation Sequencing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Next-Generation Sequencing Market make the report investor’s guide.
Global Next-Generation Sequencing Market Key Developments:

BGI Genomics and genomiQa signed a service agreement for WGS on DNBseq in March 2019. This arrangement allowed patients to gain access to actionable data, resulting in a wider customer base.

Illumina teamed up with the Lundbeck Foundation GeoGenetics Centre in Denmark in March 2019 to create a connection between infectious and neurological diseases while also lowering the cost of its service to about USD 100.

Veritas Genetics reported in July 2019 that the cost of its WGS services will be reduced from USD 999 to USD 599, with a retail price range of USD 100–200 anticipated shortly.

In August 2020, Quest Diagnostics launched an integrated next-generation sequencing engine for AncestryHealth samples.

Illumina announced several oncology collaborations in January 2021, including Merck, Myriad Genetics, Kura Oncology, and Bristol Myers Squibb, to extend the use and scope of its TruSight Oncology pan-cancer assay.

The Thalassemia Gene Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method), which can be used for the genetic diagnosis of á, â thalassemia, and other hemoglobinopathies as well as general population carrier screening, earned CE mark clearance in January 2021.

 

For More Information Visit :https://www.maximizemarketresearch.com/market-report/next-generation-sequencing-market/100124/

 

The Oncomine Dx Aim Test, an NGS-based companion diagnostic (CDx) test to detect RET fusion-positive, metastatic non-small cell lung cancer (NSCLC) patients undergoing GAVRETO (pralsetinib), a targeted therapy created by Blueprint Medicines, obtained premarket clearance from the US FDA in September 2020
Global Next-Generation Sequencing Market Scope: Inquire before buying

Global Next-Generation Sequencing Market, by Product & Services

 NGS Consumables
• Exome & Targeted Resequencing & Custom Panel
• Whole-Genome Sequencing & De Novo Sequencing
• RNA Sequencing
• Other Sequencing Services
 Sequencing Services
 Presequencing Products & Services
• Library Preparation & Target Preparation
• Quality Control
 NGS Platforms
• Illumina
o Novaseq Systems
o Nextseq Systems
o Miseq Systems
o Miniseq Systems
o iSeq Systems
• Thermo Fisher Scientific
o ION PGM Systems
o ION Proton System
o ION Genestudio Systems
o Ion Torrent Genexus Systems
• Oxford Nanopore Technologies
• Pacific Biosciences
• Other Platforms
 Bioinformatics
o Services
o NGS Software & Workbenches
o NGS Storage, Management, & Cloud Computing Solutions
 Services for NGS Platforms
Global Next-Generation Sequencing Market, by Technology

 Sequencing by Synthesis
 ION Semiconductor Sequencing
 Nanopore Sequencing
 Single-Molecule Real-Time Sequencing
 Other Technologies
Global Next-Generation Sequencing Market, by Application

 Diagnostics
 Drug Discovery
 Agricultural & Animal Research
 Other Applications
Global Next-Generation Sequencing Market, by End User

 Academic Institutes & Research Centers
 Pharmaceutical & Biotechnology Companies
 Hospitals & Clinics
 Other End Users
Global Next-Generation Sequencing Market, by Region

 North America
 Europe
 Asia Pacific
 The Middle East and Africa
 South America
Global Next-Generation Sequencing Market Key Players

 Illumina
 QIAGEN
 Thermo Fisher Scientific, Inc.
 F. Hoffman-La Roche Technologies
 Genomatrix GmbH
 PierianDx
 DNASTAR, Inc.
 Eurofins GATC Biotech GmbH
 Perkin Elmer, Inc.
 BGI
 Bio Rad Laboratories, Inc.
 Other Key Players

 

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

 

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Comments are closed